The global Auditory Brainstem Implant market is expected to reach US$ 114.67 million in 2030 from US$ 61.19 million in 2022. The market is estimated to grow with a CAGR of 8.2% from 2022 to 2030.

The key factors driving the market's growth include the growing prevalence of sensorineural hearing loss and technological advancements in ABI devices. However, the high costs of surgical treatments and limited reimbursement policies hamper the market growth.

Market Drivers of the Auditory Brainstem Implant Market

An auditory brainstem implant (ABI) is similar to the cochlear implant (CI) used to provide hearing perception to children and adults with hearing disabilities. Unlike CIs, the ABI directly stimulates the second-order neurons of the cochlear nucleus. This stimulation can help patients who cannot receive a CI or have retrocochlear deafness, such as those with NF2, to regain their auditory abilities. In an article published by StatPearls in 2023, the US reports 5 to 27 cases of sudden sensorineural hearing loss (SNHL) per 100,000 people yearly, resulting in ~66,000 new cases annually. In addition, ~16% of adults worldwide with disabling hearing loss have noise-induced hearing loss (NIHL), another significant cause of hearing loss in adults related to occupational noise. It remains a common occupational disease despite legislation to prevent NIHL in most developed countries. Many studies have found that ABIs successfully restore hearing for Neurofibromatosis type 2 (NF2) patients with bilateral deafness. In an article published by Wolters Kluwer in February 2021, a study was carried out to assess auditory brainstem implantation in a case of a 65-year-old male diagnosed with bilateral cochlear otosclerosis and profound sensorineural hearing loss. The study concluded that extensive otosclerosis of the cochlea may lead to a poor outcome of cochlear implantation. An Auditory Brainstem Implant (ABI) could be considered an alternative treatment for profound sensorineural hearing loss in deaf children and adults who receive little or no benefit from hearing aids and aren't suitable candidates for cochlear implants.

Furthermore, the availability of advanced hearing implants equipped with innovative technologies has improved their effectiveness in treating hearing impairments. This, combined with minimally invasive surgical approaches, has played a significant role in the growth and prominence of the auditory brainstem implant market.

Opportunities in the Auditory Brainstem Implant Market

Novel technologies that optimize the ABI-neural tissue interface are being developed to improve performance while minimizing adverse effects. Innovative advances in optogenetics and bioengineering provide opportunities to continuously evolve this technology in the future, improving spatial selectivity of neuronal activation in the cochlear nucleus and preventing side effects through reduced activation of non-target neuronal circuitry. These developments help in improving surgical planning and, as a result, patients' audiological capacities.

Auditory Brainstem Implant Market: Segmental Overview

The auditory brainstem implant market is segmented based on components into microphones, decoding chips, and electrodes. The microphone segment held the highest market share from 2020 to 2030.

Based on age group, the auditory brainstem implant market is bifurcated into adults and pediatrics. The adult segment is anticipated to hold a larger revenue share in the global market during 2022-2030.

Based on application, the auditory brainstem implant market is bifurcated into sensorineural and conductive hearing loss. The sensorineural hearing loss segment held a larger market share in 2022.

Based on the end user, the auditory brainstem implant market is categorized into hospitals, ENT clinics, and ambulatory surgical centers. The hospital segment will register the highest CAGR in the market from 2022 to 2030. Auditory brainstem implants involve complicated surgeries that need specialized medical attention, including diagnosis, treatment, and ongoing monitoring. Hospitals play an essential role in delivering complete healthcare services to patients.

Auditory Brainstem Implant Market: Geographical Overview

Asia Pacific is estimated to register the highest CAGR from 2022 to 2030. Countries such as India and China hold significant potential for the growth of the Auditory Brainstem Implant treatments market. Developing countries in the region with improving healthcare infrastructure, a rising focus on adopting advanced neuroprosthetic technologies, and increasing healthcare expenditure offer opportunities for market expansion.

In 2022, North America held the largest share of the global Auditory Brainstem Implant market size. The US has a high prevalence of hearing loss, which propels the growth of the Auditory Brainstem Implant market. As per the statistics published by the Centers for Disease Control and Prevention (CDC) in August 2023, over 98% of infants in the US were checked for hearing loss, and ~ 6,000 newborns born in 2019 were diagnosed with irreversible hearing loss at birth. Thus, the high prevalence of hearing loss among people in the US has led to increasing adoption of ABIs, which in turn fuels the region's Auditory Brainstem Implant market growth.